Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Galen is a specialty pharmaceutical company that focuses on the commercialization of branded generic and innovative medicines across various therapeutic areas. As a member of the Almac Group, the company operates globally with a significant presence in the Nordic region through its Stockholm-based office, Galen Nordics. Its portfolio primarily includes products for gastroenterology, pain management, dermatology, and clinical nutrition. Galen provides a range of services including product acquisition, marketing, and distribution to healthcare providers. The company is well-known for established brands such as Laxido and Adcal-D3, which serve large patient populations in Europe and beyond.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Galen Nordics.